insights_auto
为什么 PTKFY 下跌了 12.76%?
深入探索chevron_right
PTKFY:OTCMKTS
卡尔贝制药公司
US$7.42
arrow_downward
-12.76%(-1.08) 1 天
10月19日, GMT-4 12:00:58 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 PTKFY 生成关键数据洞见…
开盘价
US$7.46
最高价
US$7.46
最低价
US$7.21
市值
30.66万亿
平均成交量
1938.00
成交量
546.00
52 周最高价
US$16.36
52 周最低价
US$7.21
Beta 版
0.09
流通股数
2.34亿
员工人数
1万
开盘价
US$7.46
最高价
US$7.46
最低价
US$7.21
市值
30.66万亿
平均成交量
1938.00
成交量
546.00
52 周最高价
US$16.36
52 周最低价
US$7.21
Beta 版
0.09
流通股数
2.34亿
员工人数
1万
新闻报道
来自网络来源和新闻合作伙伴
ad-hoc-news.de
·
3小时前
Kalbe Farma stock: UOB cites IDR 770 for Kalbe Farma stock
ad-hoc-news.de
·
10小时前
Kalbe Farma cancels IDR 500 billion buyback for Kalbe Farma stock
ad-hoc-news.de
·
11小时前
Kalbe Farma stock pre-market ahead of the Xetra open
资料
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
卡尔贝制药公司简介